SusanSwindellsMD
Infectious Disease • Omaha, NEProfessor, Internal Medicine, University of Nebraska Medical Center College of Medicine
Are you Dr. Swindells?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 12 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
988102 Nebraska Medical Ctr
Omaha, NE 68198Phone+1 402-559-2666Fax+1 402-559-2677- Is this information wrong?
Summary
- Dr. Susan Swindells, MD is an infectious disease specialist in Omaha, Nebraska. She is currently licensed to practice medicine in Nebraska, Iowa, and Ohio. She is affiliated with Nebraska Medicine - Nebraska Medical Center and is a Professor at University of Nebraska Medical Center College of Medicine.
Education & Training
University of WashingtonResidency, Family Medicine, 1979 - 1980
University of London Faculty of MedicineClass of 1977
Certifications & Licensure
NE State Medical License 1991 - 2024
IA State Medical License 1995 - 2014
OH State Medical License 1988 - 2004
WI State Medical License 1985 - 2001
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Atazanavir/Ritonavir Maintenance Therapy Start of enrollment: 2004 Jul 01
- Observational Study of Specificity of Mycobacterium Tuberculosis Screening and Diagnostics in HIV-Infected Individuals Start of enrollment: 2009 Dec 01
- Chronic HIV Infection and Aging in NeuroAIDS (CHAIN) Start of enrollment: 2010 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- Twice-Daily Dolutegravir Based Antiretroviral Therapy with One Month of Daily Rifapentine and Isoniazid (1HP) for TB Prevention.Anthony T Podany, Yoninah Cramer, Marjorie Imperial, Susan L Rosenkranz, Anchalee Avihingsanon, Wadzanai Samaneka, Irina Gelmanova, Rada Savic, Rodney Dawson, Anne F L...> ;Clinical Infectious Diseases. 2024 Apr 3
- High-Dose Isoniazid Lacks EARLY Bactericidal Activity Against Isoniazid-resistant Tuberculosis Mediated by katG Mutations: A Randomized, Phase 2 Clinical Trial.Kamunkhwala Gausi, Elisa H Ignatius, Veronique De Jager, Caryn Upton, Soyeon Kim, Ashley McKhann, Laura Moran, Lubbe Wiesner, Florian von Groote-Bidlingmaier, Philip M...> ;American Journal of Respiratory and Critical Care Medicine. 2024 Apr 2
- Preferences and feasibility of long-acting technologies for treatment of hepatitis C virus in low- and middle-income countries: A survey of providers and policymakers.Neil Gupta, Kimberly K Scarsi, Renae Furl, Joelle Dountio Ofimboudem, Hailemichael Desalegn, Saeed Hamid, Alethse de la Torre Rosas, Angelica E Miranda, Andrew Owen, S...> ;Journal of Viral Hepatitis. 2024 May 1
- Join now to see all
Press Mentions
UNMC for the RecordOctober 8th, 2021- Gilead’s Lenacapavir: HIV Prospects Strongest in Long-Acting Combos with Merck’s IslatravirAugust 25th, 2021
- HIV: Failed Viral Suppression in CAB/RPV Linked to Three Risk FactorsJuly 27th, 2021
- Join now to see all
Hospital Affiliations
Nebraska Medicine - Nebraska Medical CenterOmaha, Nebraska
